Private practice with Dr Seth Bilazarian

View all posts »

Email: What role as a tool to communicate with patients?

Feb 23, 2012 16:45 EST


It's simple, widely used, and essentially free, but complex issues—such as legal liability, restrictions on use imposed by a private practice or hospital, and time constraints—make it impossible to use email to correspond with our patients. Is this a good thing? In an age of rapid accessibility, how do you feel about using email to correspond with your patients?

To view Dr Bilazarian's presentation, click here.

See:

Talking about a (healthcare) revolution: The digital age ushers in precision medicine





« Previous Post
"Go to the emergency room"
Mar 2, 2012 14:15 EST Next post »
Social media: What role for the community-based cardiologist?
Feb 14, 2012 10:25 EST



Your comments
Email: What role as a tool to communicate with patients?
# 1 of 1
February 24, 2012 03:04 (EST)
James J. King
Wow, this 21st century has certainly become a (redacted) for cardiologist. How is all this compensated? I would think, shouldn't a dedicated Pharmacist be the first in the loop, with a primary care provider and then the specialist? The legal liability for this system seems unacceptable in the USA. The e-mail page would need with bullets of 1. Medications, prescribed and actually taken, 2. Over the counter treatments, 3. Problem list, with onset and recent therapies. 4 Question.

You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Forgot your username and/or password?
        Login        
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

    Join now for full access    
About Dr Seth Bilazarian
Seth Bilazarian MD has been a Clinical and Interventional Cardiologist at Pentucket Medical Associates in Massachusetts since 1993. He is board certified in Internal Medicine, Cardiovascular Medicine, Nuclear Cardiology, Vascular Ultrasound, Interventional Cardiology, and Vascular and Endovascular Medicine.

Dr Bilazarian performs coronary and peripheral interventions at Lahey Clinic and Massachusetts General Hospital. He has been an investigator in the interventional laboratory for new devices including drug-eluting stents, distal protection devices, imaging devices (OCT and InfraRed), and anticoagulant pharmacotherapy.

Dr Bilazarian is an active participant in clinical trials in congestive heart failure, hypertension, coronary disease prevention, prediabetes management, anemia, atrial fibrillation, and anticoagulation/antiplatelet therapies in the outpatient setting. He has authored numerous papers and book chapters in clinical cardiology. He was appointed as a physician advisor to the circulatory device panel of the FDA in 2008.
About this blog
My intent is to create a forum for dialogue on issues pertinent to private practice cardiology around topics such as:

  • Integration of new data and guidelines on inpatient and outpatient practice in clinical and interventional cardiology
  • Practice approaches to the extra clinical issues in dealing with managed care insurers
  • Strategies for navigating the restrictions of pharmacy benefits managers (PBMs) on pharmacologic therapies for our patients
  • Experiences with restrictions on testing and imaging
The video blog (VLOG) will provide an opportunity to share broadly different approaches to the common conundrums we face in caring for patients. My hope is that this forum will provide useful data points for practice outside of tertiary and academic centers and a look inside community hospitals and physician?s practice patterns in the office, starting with mine.